stockportfolio.pro
Hinge Health, Inc. (HNGE)
Healthcare · Health Information Services · NYSE
Hinge Health, Inc. revenue & earnings — last 3 fiscal years
| Metric | 2023 | 2024 | 2025 |
|---|---|---|---|
| Revenue | $292.73M | $390.40M | $587.86M |
| Gross profit | $194.18M | $299.90M | $468.22M |
| Net income | $-108.14M | $-11.93M | $-528.26M |
| Net margin | -36.9% | -3.1% | -89.9% |
Source: Hinge Health, Inc. SEC filings (10-K).
What growth is priced into HNGE stock?
At today's market cap of $5.01B, Hinge Health, Inc. is priced for free-cash-flow growth of about 13.4% per year for 10 years (assuming a 10% discount rate and 2.5% terminal growth, base FCF $165.38M from the FY ending 2025-12-31). This is a reverse DCF — a translation of the price into a growth assumption you can judge, not a fair value and not advice. Change the assumptions yourself in the interactive view →
Explore 3 years of Hinge Health, Inc. financials — interactive
Full income statement, balance sheet and cash flow with CAGR and trend on every row, 48 quarters, valuation ratios, plain-English health checks, and Ask — our SEC-grounded research assistant.
Open the interactive view — freeOr start a 7-day free trial to track HNGE in your portfolio →
Hinge Health, Inc. financial history by metric
About Hinge Health, Inc.
Hinge Health, Inc. focuses on building a health system that scales and automates the delivery of care using technology. It designs its platform to address musculoskeletal system care (MSK), including acute injury, chronic pain, and post-surgical rehabilitation. The company also provides personalized and automated MSK care through AI-powered motion tracking technology and a proprietary electrical nerve stimulation wearable device. It primarily serves self-insured employers. The company was founded in 2012 and is headquartered in San Francisco, California.
Hinge Health, Inc. — frequently asked questions
What is Hinge Health, Inc.'s revenue?
Hinge Health, Inc. (HNGE) reported revenue of $587.86M for fiscal year 2025, up 50.6% from the prior year, according to its SEC filings.
Is Hinge Health, Inc. profitable?
No — HNGE reported a net loss of $-528.26M in fiscal 2025.
What is HNGE's P/E ratio?
Hinge Health, Inc. trades at a price-to-earnings ratio of about 0.0 based on the latest data in our nightly-refreshed cache.
How fast is Hinge Health, Inc. growing?
HNGE's revenue grew at roughly 41.7% per year over the last five fiscal years (compound annual growth rate), computed from SEC-filed statements.
How much debt does Hinge Health, Inc. have?
As of fiscal year 2025, HNGE carried roughly $0 in total debt (short- plus long-term borrowings), per its filed balance sheet.
What is Hinge Health, Inc.'s gross margin?
HNGE's gross margin was 79.6% in fiscal 2025 — gross profit of $468.22M on revenue of $587.86M.
What is Hinge Health, Inc.'s market cap?
Hinge Health, Inc. (HNGE) has a market capitalization of about $5.01B, based on the latest data in our nightly-refreshed cache.
When does Hinge Health, Inc.'s fiscal year end?
HNGE's fiscal year ends in December. Its most recent annual filing covers the fiscal year ending 2025-12-31.
What growth is priced into HNGE stock?
At today's market cap of $5.01B, Hinge Health, Inc. is priced for free-cash-flow growth of about 13.4% per year for 10 years (assuming a 10% discount rate and 2.5% terminal growth, base FCF $165.38M from the FY ending 2025-12-31).
Where does this data come from?
All figures are computed from Hinge Health, Inc.'s official SEC filings (10-K and 10-Q), covering 3 years of history, refreshed nightly. stockportfolio.pro does not provide investment advice.